New Jersey · 2026-2027 Regular Session · Bill

A 3242: Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease.

Passed one chamber Last action October 29, 2026: Passed by the Assembly (72-0-5)

Plain-language summary

A 3242 is a bill introduced in the New Jersey House on January 13, 2026. According to its official title, it concerns: Requires health benefits coverage of continuous glucose monitoring system for treatment of glycogen storage disease. Primary sponsor: Dan Hutchison (Democratic), Donlon, Margie, M.D., Heather Simmons (Democratic). It lists 5 additional sponsors. Most recent recorded action (October 29, 2026): Passed by the Assembly (72-0-5).

Sponsors

Primary sponsors: Dan Hutchison (Democratic); Donlon, Margie, M.D.; Heather Simmons (Democratic). 5 co-sponsors.